Weds Cure Talk: Targeting Stem Cells in Multiple Myeloma for Improved Outcomes

Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of a drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are talking to Dr. William Matsui of Johns Hopkins University School of Medicine to get a better understanding of the drivers of these functions and how they may lead to novel therapies for relapsed disease. 

Dec 20, 2 PM west Coast/5 PM east coast

https://www.curetalks.com/event/rsvp/Targeting-Stem-Cells-in-Multiple-Myeloma-for-Improved-Outcomes/291/?upcoming=yes